Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
2417897-14-6
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Relay_Therapeutics
|
| gptkbp:hasMolecularFormula |
C22H23N5O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
RLY-1971
|
| gptkbp:isApprovedDrug |
true
|
| gptkbp:IUPACName |
N-(4-(4-methylpiperazin-1-yl)phenyl)-4-(1H-pyrazol-4-yl)pyrimidine-2-carboxamide
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:target |
gptkb:HPK1
gptkb:MAP4K1 |
| gptkbp:therapeuticArea |
oncology
|
| gptkbp:bfsParent |
gptkb:Relay_Therapeutics
|
| gptkbp:bfsLayer |
6
|